Cited by 297RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryCRISPR and Genetic Engineering

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles

Open access

Chen, Zeming, Liu, Fuyao, Chen, Yanke, Liu, Jun, Wang, Xiaoying, Chen, Ann T., Deng, Gang, Zhang, Hongyi, Liu, Jie, Hong, Zhangyong, Zhou, Jiangbing·2017·Advanced Functional Materials

DOI 10.1002/adfm.201703036PMC PMC5939593

Open this paper in CoChat — free account

Abstract

Due to its simplicity, versatility, and high efficiency, the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology has emerged as one of the most promising approaches for treatment of a variety of genetic diseases, including human cancers. However, further translation of CRISPR/Cas9 for cancer gene therapy requires development of safe approaches for efficient, highly specific delivery of both Cas9 and single guide RNA to tumors. Here, novel core-shell nanostructure, liposome-templated hydrogel nanoparticles (LHNPs) that are optimized for efficient codelivery of Cas9 protein and nucleic acids is reported. It is demonstrated that, when coupled with the minicircle DNA technology, LHNPs deliver CRISPR/Cas9 with efficiency greater than commercial agent Lipofectamine 2000 in cell culture and can be engineered for targeted inhibition of genes in tumors, including tumors the brain. When CRISPR/Cas9 targeting a model therapeutic gene, polo-like kinase 1 (PLK1), is delivered, LHNPs effectively inhibit tumor growth and improve tumor-bearing mouse survival. The results suggest LHNPs as versatile CRISPR/Cas9-delivery tool that can be adapted for experimentally studying the biology of cancer as well as for clinically translating cancer gene therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/adfm.201703036

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citation
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon, D., Goodwin, M. J., Aryee, M. J., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2908 · Cited by 952
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N. S., Cai, W., Yang, G., Bronson, R., Crowley, D. G., et al. (2014) · Nature · doi:10.1038/nature13589 · Cited by 776

Show all 41 references

Research works printed but not linked: 2

10.1126/science.1225829 · DOI · Paper page
10.1038/nmeth.3047 · DOI · Paper page

Sorted by citations

CRISPR technology: A decade of genome editing is only the beginning
Wang, J. Y., & Doudna, J. A. (2023) · Science · doi:10.1126/science.add8643 · Cited by 1,105
Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 762
Recent advancements in liposome technology
Filipczak, N., Pan, J., Yalamarty, S. S. K., & Torchilin, V. P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.022 · Cited by 611
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology
Hersh, A. M., Alomari, S., & Tyler, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084153 · Cited by 478
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W.-M. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 499
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
Zhang, S., Shen, J., Li, D., & Cheng, Y. (2021) · Theranostics · doi:10.7150/thno.47007 · Cited by 430
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415
Hydrogels for RNA delivery
Zhong, R., Talebian, S., Mendes, B. B., Wallace, G. G., Langer, R., Conde, J., & Shi, J. (2023) · Nature Materials · doi:10.1038/s41563-023-01472-w · Cited by 391
Tailoring Gelation Mechanisms for Advanced Hydrogel Applications
Nele, V., Wojciechowski, J. P., Armstrong, J. P. K., & Stevens, M. M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002759 · Cited by 300
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Jain, V. K., Kumar, H., Anod, H. V., Chand, P., Gupta, N., Dey, S., & Kesharwani, S. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.003 · Cited by 295
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 300
Self-citation
Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
Zhang, P., Xiao, Y., Sun, X. F., Lin, X., Koo, S., Yaremenko, A. V., Qin, D., Kong, N., Farokhzad, O. C., & Tao, W. (2022) · Med · doi:10.1016/j.medj.2022.12.001 · Cited by 265
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
Song, X., Liu, C., Wang, N., Huang, H., He, S., Gong, C., & Wei, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.010 · Cited by 217
Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
Lv, Q., Cheng, L., Lu, Y., Zhang, X., Wang, Y., Deng, J., Zhou, J., Liu, B., & Liu, J. (2020) · Advanced Science · doi:10.1002/advs.202000515 · Cited by 211
Self-citation
Engineered materials for in vivo delivery of genome-editing machinery
Tong, S., Moyo, B., Lee, C. M., Leong, K. W., & Bao, G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0145-9 · Cited by 208
Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
Chen, F., Alphonse, M., & Liu, Q. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1609 · Cited by 197
Rational designs of in vivo CRISPR-Cas delivery systems
Xu, C., Chen, G., Luo, Y., Zhang, Y., Zhao, G., Lu, Z.-D., Czarna, A., Gu, Z., & Wang, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.005 · Cited by 187
Liposome-based delivery of biological drugs
Magar, K. T., Boafo, G. F., Li, X., Chen, Z., & He, W. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.020 · Cited by 189
Self-citation
Bioengineered nanogels for cancer immunotherapy
Ma, X., Li, S., Liu, Y., Zhang, T., Xue, P., Kang, Y., Sun, Z., & Xu, Z. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00247g · Cited by 186
Nanostructured particles assembled from natural building blocks for advanced therapies
Ju, Y., Liao, H., Richardson, J. J., Guo, J., & Caruso, F. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00343g · Cited by 157
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
Wang, J., Zhu, M., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113974 · Cited by 153
Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases
Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903618 · Cited by 144
Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
Lin, Y., Wagner, E., & Lächelt, U. (2022) · Biomaterials Science · doi:10.1039/d1bm01658j · Cited by 148
Aptamer/Peptide‐Functionalized Genome‐Editing System for Effective Immune Restoration through Reversal of PD‐L1‐Mediated Cancer Immunosuppression
He, X., Ren, X., Peng, Y., Zhang, J., Ai, S., Liu, B., Xu, C., & Cheng, S. (2020) · Advanced Materials · doi:10.1002/adma.202000208 · Cited by 138
Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
Wei, T., Cheng, Q., Farbiak, L., Anderson, D. G., Langer, R., & Siegwart, D. J. (2020) · ACS Nano · doi:10.1021/acsnano.0c04707 · Cited by 143
Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches
Kansız, S., & Elçin, Y. M. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102930 · Cited by 133
Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
Basso, J., Miranda, A., Nunes, S. C. C., Cova, T. F. G. G., Sousa, J., Vitorino, C., & Pais, A. A. C. C. (2018) · Gels · doi:10.3390/gels4030062 · Cited by 127
Nanogels: Synthesis, properties, and recent biomedical applications
Duan, Q., Zhu, Y., Jia, H., Wang, S., & Wu, F. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101167 · Cited by 124
Material solutions for delivery of CRISPR/Cas-based genome editing tools: Current status and future outlook
Wan, T. Y., Niu, D., Wu, C., Xu, F., Church, G. M., & Yuan, P. (2019) · Materials Today · doi:10.1016/j.mattod.2018.12.003 · Cited by 119
Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
Ryu, J., Won, E.-J., Lee, H. A. R., Kim, J. H., Hui, E., Kim, H.-P., & Yoon, T. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119736 · Cited by 118
Non-Viral Delivery To Enable Genome Editing
Rui, Y., Wilson, D. R., & Green, J. J. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.08.010 · Cited by 115
Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system
Moghassemi, S., Dadashzadeh, A., Azevedo, R. B., Féron, O., & Amorim, C. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.024 · Cited by 112
Cationic Polymer‐Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing
Zhang, Z., Wan, T. Y., Chen, Y., Chen, Y., Sun, H., Cao, T., Songyang, Z., Tang, G., Wu, C., Yuan, P., et al. (2018) · Macromolecular Rapid Communications · doi:10.1002/marc.201800068 · Cited by 109
Self-citation
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Xu, Z., Wang, Q., Zhong, H., Jiang, Y., Shi, X., Yuan, B., Yu, N., Zhang, S., Yuan, X., Guo, S., et al. (2022) · Exploration · doi:10.1002/exp.20210081 · Cited by 105
Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles
Wan, F., Draz, M. S., Gu, M., Yu, W., Ruan, Z., & Luo, Q. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030352 · Cited by 106
Hydrogel Properties and Their Impact on Regenerative Medicine and Tissue Engineering
Chyzy, A., & Plonska-Brzezinska, M. E. (2020) · Molecules · doi:10.3390/molecules25245795 · Cited by 106
Gold Nanocluster-Mediated Efficient Delivery of Cas9 Protein through pH-Induced Assembly-Disassembly for Inactivation of Virus Oncogenes
Ju, E., Li, T., da Silva, S. R., & Gao, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12335 · Cited by 103
Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods
Mashel, T. V., Tarakanchikova, Y. V., Muslimov, A. R., Zyuzin, M. V., Timin, A. S., Lepik, K. V., & Fehse, B. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120282 · Cited by 102
Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches
Caraway, C. A., Gaitsch, H., Wicks, E. E., Kalluri, A. L., Kunadi, N., & Tyler, B. (2022) · Polymers · doi:10.3390/polym14142963 · Cited by 102
Smart hydrogel: A new platform for cancer therapy
Li, G., Fu, Z.-M., Li, H., Wei, R., Guo, J., Wang, H., & Qi, J. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103470 · Cited by 100
Bioactive injectable hydrogels for on demand molecule/cell delivery and for tissue regeneration in the central nervous system
Grimaudo, M. A., Krishnakumar, G. S., Giusto, E., Furlani, F., Bassi, G., Rossi, A., Molinari, F., Lista, F. R., Montesi, M., & Panseri, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.038 · Cited by 98
Human HSP70 Promoter‐Based Prussian Blue Nanotheranostics for Thermo‐Controlled Gene Therapy and Synergistic Photothermal Ablation
Liu, Y., Shu, G., Li, X., Chen, H., Zhang, B., Pan, H., Li, T., Gong, X., Wang, H., Wu, X., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802026 · Cited by 92
Biomaterials as vectors for the delivery of CRISPR–Cas9
Eoh, J. H., & Gu, L. (2019) · Biomaterials Science · doi:10.1039/c8bm01310a · Cited by 92
Liposomal delivery of antibiotic loaded nucleic acid nanogels with enhanced drug loading and synergistic anti-inflammatory activity against S. aureus intracellular infections
Obuobi, S. A. O., Julin, K., Fredheim, E. G. A., Johannessen, M., & Škalko‐Basnet, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.002 · Cited by 90
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Chen, Y., & Zhang, Y. (2018) · Advanced Science · doi:10.1002/advs.201700964 · Cited by 91
Self-citation
Controllable assembly/disassembly of polyphenol-DNA nanocomplex for cascade-responsive drug release in cancer cells
Han, J., Cui, Y., Gu, Z., & Yang, D. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120846 · Cited by 89
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 96
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
Sinclair, F., Begum, A. A., Dai, C. C., Tóth, I., & Moyle, P. M. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01320-z · Cited by 91
Non-viral gene therapy using multifunctional nanoparticles: Status, challenges, and opportunities
Lin, G., Li, L., Panwar, N., Wang, J., Tjin, S. C., Wang, X., & Yong, K. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.07.001 · Cited by 88
Self-citation
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Rahimi, H., Salehiabar, M., Charmi, J., Barsbay, M., Ghaffarlou, M., Razlighi, M. R., Davaran, S., Khalilov, R. I., Sugiyama, M., Nosrati, H., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100895 · Cited by 83
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 85
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Liu, B., Saber, A., & Haisma, H. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.011 · Cited by 86
Recent advances in liposome formulations for breast cancer therapeutics
Yang, B., Song, B.-P., Shankar, S., Guller, A., & Deng, W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03850-6 · Cited by 82
Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment
Marino, A., Camponovo, A., Degl’Innocenti, A., Bartolucci, M., Tapeinos, C., Martinelli, C., Pasquale, D. D., Santoro, F., Mollo, V., Arai, S., et al. (2019) · Nanoscale · doi:10.1039/c9nr07976a · Cited by 78
Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing
Tao, Y., Yi, K., Hu, H., Shao, D., & Li, M. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01925a · Cited by 78
Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
Kong, H., Ju, E., Yi, K., Xu, W., Lao, Y., Cheng, D., Zhang, Q., Tao, Y., Li, M., & Ding, J. (2021) · Advanced Science · doi:10.1002/advs.202102051 · Cited by 77
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Sahel, D. K., Vora, L. K., Saraswat, A. L., Sharma, S., Monpara, J. D., D’souza, A. A., Mishra, D., Tryphena, K. P., Kawakita, S., Khan, S. U., et al. (2023) · Advanced Science · doi:10.1002/advs.202207512 · Cited by 79
Liposome-integrated hydrogel hybrids: Promising platforms for cancer therapy and tissue regeneration
Sanati, M., & Yavari, S. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.008 · Cited by 77
Fluorinated Acid‐Labile Branched Hydroxyl‐Rich Nanosystems for Flexible and Robust Delivery of Plasmids
Yu, Q., Song, H., Xiao, H., Cheng, G., Yu, B., & Xu, F. (2018) · Small · doi:10.1002/smll.201803061 · Cited by 75
In Situ Loading and Delivery of Short Single- and Double-Stranded DNA by Supramolecular Organic Frameworks
Yang, B., Zhang, X., Li, J., Tian, J., Wu, Y.-P., Yu, F., Wang, R., Wang, H., Zhang, D., Liu, Y., et al. (2019) · CCS Chemistry · doi:10.31635/ccschem.019.20180011 · Cited by 75
LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy
Chen, Y., Jiang, T., Zhang, H., Gou, X., Han, C., Wang, J., Chen, A. T., Ma, J., Liu, J., Chen, Z., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00586-6 · Cited by 73
Self-citation
Innovative approaches to combat antibiotic resistance: integrating CRISPR/Cas9 and nanoparticles against biofilm-driven infections
Natanzi, A. S., Poudineh, M., Karimi, E., Khaledi, A., & Kashani, H. H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04323-4 · Cited by 77
Inherent and Composite Hydrogels as Promising Materials to Limit Antimicrobial Resistance
Carpa, R., Remizovschi, A., Culda, C. A., & Butiuc-Keul, A. L. (2022) · Gels · doi:10.3390/gels8020070 · Cited by 72
Developing hydrogels for gene therapy and tissue engineering
Su, C., Lin, D., Huang, X., Feng, J., Jin, A., Wang, F., Lv, Q., Lei, L., & Pan, W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02462-z · Cited by 75
Preparation, formation mechanism and in vitro dynamic digestion behavior of quercetin-loaded liposomes in hydrogels
Liu, W., Kong, Y., Ye, A., Shen, P., Dong, L., Xu, X., Hou, Y., Wang, Y., Jin, Y., & Han, J. (2020) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2020.105743 · Cited by 71
Design and application of stimuli-responsive DNA hydrogels: A review
Wang, Z., Chen, R., Yang, S., Li, S., & Gao, Z. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100430 · Cited by 71
Polysaccharide-based hydrogels for drug delivery and wound management: a review
Sanjanwala, D., Londhe, V. Y., Trivedi, R., Bonde, S., Sawarkar, S. P., Kale, V., & Patravale, V. B. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2152791 · Cited by 71
Progress on intelligent hydrogels based on RAFT polymerization: Design strategy, fabrication and the applications for controlled drug delivery
Xian, C., Yuan, Q., Bao, Z., Liu, G., & Wu, J. (2019) · Chinese Chemical Letters · doi:10.1016/j.cclet.2019.03.052 · Cited by 69
Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
Deng, H., Huang, W., & Zhang, Z. (2019) · Nano Research · doi:10.1007/s12274-019-2465-x · Cited by 70
Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy
Li, C., Yang, T., Weng, Y., Zhang, M., Zhao, D., Guo, S., Hu, B., Shao, W., Wang, X., Hussain, A., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.051 · Cited by 69
Self-citation
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
Allemailem, K. S., Alsahli, M. A., Almatroudi, A., Alrumaihi, F., Alkhaleefah, F. K., Rahmani, A. H., & Khan, A. A. (2022) · 癌症：英文版 · doi:10.1002/cac2.12366 · Cited by 69
Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing
Iqbal, Z., Rehman, K., Xia, J., Shabbir, M., Zaman, M., Liang, Y., & Duan, L. (2023) · Biomaterials Science · doi:10.1039/d2bm01636b · Cited by 71
Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment
Aghamiri, S., Talaei, S., Ghavidel, A. A., Zandsalimi, F., Masoumi, S., Hafshejani, N. H., & Jajarmi, V. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101533 · Cited by 70
Recent trends in the development of hydrogel therapeutics for the treatment of central nervous system disorders
Li, Q., Shao, X., Dai, X., Guo, Q., Yuan, B., Liu, Y., & Jiang, W. (2022) · NPG Asia Materials · doi:10.1038/s41427-022-00362-y · Cited by 69
NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment
Liu, Q., Cai, J., Zheng, Y., Tan, Y., Wang, Y., Zhang, Z., Zheng, C., Zhao, Y., Liu, C., An, Y., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02501 · Cited by 67
Block Polymer Micelles Enable CRISPR/Cas9 Ribonucleoprotein Delivery: Physicochemical Properties Affect Packaging Mechanisms and Gene Editing Efficiency
Tan, Z., Jiang, Y., Ganewatta, M. S., Kumar, R., Keith, A. R., Twaroski, K., Pengo, T., Tolar, J., Lodge, T. P., & Reineke, T. M. (2019) · Macromolecules · doi:10.1021/acs.macromol.9b01645 · Cited by 69
Liposomes modified with bio-substances for cancer treatment
Li, Y., Cong, H., Wang, S., Yu, B., & Shen, Y. (2020) · Biomaterials Science · doi:10.1039/d0bm01531h · Cited by 66
Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
Yi, K., Kong, H., Lao, Y., Li, D., Mintz, R. L., Fang, T., Chen, G., Tao, Y., Li, M., & Ding, J. (2023) · Advanced Materials · doi:10.1002/adma.202300665 · Cited by 66
Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy
Wang, L., Zheng, W., Liu, S., Li, B. J., & Jiang, X. (2018) · ChemBioChem · doi:10.1002/cbic.201800629 · Cited by 66
Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System
Aksoy, Y. A., Yang, B., Chen, W., Hung, T., Kuchel, R. P., Zammit, N. W., Grey, S. T., Goldys, E. M., & Deng, W. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c16380 · Cited by 63
Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages
Zhang, Y., Chen, Y., Li, J., Zhu, X., Liu, Y., Wang, X., Wang, H., Yao, Y., Gao, Y., & Chen, Z. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01453 · Cited by 62
Self-citation
Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy
Zhu, D., Shen, H., Tan, S., Hu, Z., Wang, L., Yu, L., Tian, X., Ding, W., Ren, C., Gao, C., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.019 · Cited by 60
Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9
Ashok, B., Peppas, N. A., & Wechsler, M. E. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102728 · Cited by 62
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Huang, K. L., Zapata, D. A., Tang, Y., Teng, Y., & Li, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121876 · Cited by 61
Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects
Cao, G., Xuan, X., Zhang, R., Hu, J. H., & Dong, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.760140 · Cited by 58
Amphiphilic and fatigue-resistant organohydrogels for small-diameter vascular grafts
Hou, J., Zhang, X., Wu, Y., Jie, J., Wang, Z., Chen, G., Sun, J., & Wu, L. (2022) · Science Advances · doi:10.1126/sciadv.abn5360 · Cited by 54
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
Chen, C., Zhong, W., Du, S., Li, Y., Zeng, Y., Liu, K., Yang, J., Guan, X., & Han, X. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.013 · Cited by 56
Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides
Kuhn, J., Lin, Y., Levačić, A. K., Danaf, N. A., Peng, L., Höhn, M., Lamb, D. C., Wagner, E., & Lächelt, U. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00853 · Cited by 54
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
Shalaby, K. E., Aouida, M., & El‐Agnaf, O. M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197353 · Cited by 55
Amphiphilic core-shell nanoparticles: Synthesis, biophysical properties, and applications
Panday, R., Poudel, A. J., Li, X., Adhikari, M., Ullah, M. W., & Yang, G. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.08.019 · Cited by 53
Artificial Bioaugmentation of Biomacromolecules and Living Organisms for Biomedical Applications
Cao, J., Zaremba, O. T., Lei, Q., Ploetz, E., Wuttke, S., & Zhu, W. (2021) · ACS Nano · doi:10.1021/acsnano.0c10144 · Cited by 53
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Biagioni, A., Laurenzana, A., Margheri, F., Chillà, A., Fibbi, G., & Rosso, M. D. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0127-2 · Cited by 52
Progress of delivery methods for CRISPR-Cas9
Yang, W., Yan, J., Zhuang, P., Ding, T., Chen, Y., Zhang, Y., Zhang, H., & Cui, W. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2100342 · Cited by 52
Self-citation
Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
Kim, D., Le, Q., Wu, Y., Park, J.-W., & Oh, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121233 · Cited by 51
Rational Design of Thermosensitive Hydrogel to Deliver Nanocrystals with Intranasal Administration for Brain Targeting in Parkinson’s Disease
Tan, Y., Liu, Y., Liu, Y., Ma, R., Luo, J., Hong, H., Chen, X., Wang, S., Liu, C., Zhang, Y., et al. (2021) · Research · doi:10.34133/2021/9812523 · Cited by 49
Multimodal targeting of glioma with functionalized nanoparticles
Marei, H. E. S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02687-8 · Cited by 48
Hydrogels for Nucleic Acid Drugs Delivery
Liu, J., Xi, Z., Fan, C., Mei, Y., Zhao, J., Jiang, Y., Zhao, M., & Xu, L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401895 · Cited by 49
Self-citation
Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes
Jain, P., Lo, J. H.-J., Rananaware, S. R., Downing, M. A., Panda, A., Tai, M., Raghavan, S., Fleming, H. E., & Bhatia, S. N. (2019) · Nanoscale · doi:10.1039/c9nr01786k · Cited by 47
CRISPR based therapeutics: a new paradigm in cancer precision medicine
Das, S., Bano, S., Kapse, P., & Kundu, G. C. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01552-6 · Cited by 47
Microenvironmental cue-regulated exosomes as therapeutic strategies for improving chronic wound healing
Dai, W., Dong, Y., Han, T., Wang, J., Gao, B., Guo, H., Xu, F., Li, J., & Ma, Y. (2022) · NPG Asia Materials · doi:10.1038/s41427-022-00419-y · Cited by 44

Authors: Chen, Z., Liu, F., Chen, Y., Liu, J., Wang, X., Chen, A. T., Deng, G., Zhang, H., Liu, J., Hong, Z., & Zhou, J.
Affiliations: Nankai University (CN)
Yale University (US)
Corresponding author: Hong, Zhangyong
Zhou, Jiangbing
ORCID: Chen, Zeming
Liu, Fuyao
Chen, Yanke
Liu, Jun
Deng, Gang
Zhang, Hongyi
Liu, Jie
Hong, Zhangyong
Zhou, Jiangbing
Venue: Advanced Functional Materials
Publisher: Wiley
Published: 2017-10-16
Volume: 27
Issue: 46
ISSN: 1616-301X (ISSN-L)
1616-3028
DOI: 10.1002/adfm.201703036
PMC: PMC5939593
OpenAlex: W2766680713
Cited by: 297
References: 41
Citations by year: 2026: 11 · 2025: 44 · 2024: 26 · 2023: 39 · 2022: 60 · 2021: 37 · 2020: 39 · 2019: 24 · 2018: 16
FWCI: 8.83
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Advanced Functional Materials (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (NS095817, NS095147)
American Brain Tumor Association
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords: CRISPR/Cas9, cancer gene therapy, core-shell nanoparticles, nucleic acid delivery, DNA minicircles, single guide RNA, targeted tumor delivery, brain tumors, PLK1, tumor growth inhibition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks